Application of non-invasive preimplantation genetic screening for aneuploidy through spent embryo culture media analysis at 48 and 54 hours after embryo cleavage - Report - MDSpire

Application of non-invasive preimplantation genetic screening for aneuploidy through spent embryo culture media analysis at 48 and 54 hours after embryo cleavage

  • By

  • Chonthicha Satirapod

  • Pornsri Niransuk

  • Siriluk Tantanavipas

  • Insee Sensorn

  • Wasun Chantratita

  • Objoon Trachoo

  • June 9, 2026

  • 0 min

Share

Utilization of Non-Invasive Preimplantation Genetic Testing for Aneuploidy Detection

Overview

This study evaluates the effectiveness of non-invasive preimplantation genetic testing (niPGT) for detecting aneuploidy at 48 and 54 hours post-cleavage. The findings indicate that the concentration of cell-free DNA in spent culture media remains consistent, but the accuracy of ploidy detection compared to trophectoderm biopsy is reported as suboptimal.

Background

Aneuploidy significantly affects the success of in-vitro fertilization (IVF), particularly in women of advanced age, leading to increased risks of miscarriage and chromosomal disorders. Preimplantation genetic testing for aneuploidy (PGT-A) is a tool for identifying chromosomal irregularities in embryos.

Data Highlights

No significant distinction in ploidy detection accuracy was observed between SCM collected from embryos at 48 hours versus those at 54 hours post cleavage. The overall accuracy for sex determination reached 79.63%.

Key Findings

['The accuracy of niPGT in ploidy detection compared to trophectoderm biopsy was 53.71%.', 'Cell-free DNA content within spent culture media remained consistent across both time points.', 'No significant difference in ploidy detection accuracy was noted between 48 and 54 hours post cleavage.', 'The study involved a cohort of 15 infertile women and a total of 58 embryos.', 'Assisted hatching was performed during the cleavage stage on Day 3.']

Clinical Implications

Clinicians should consider the reported accuracy of niPGT when discussing genetic testing options with patients undergoing IVF.

Conclusion

The study reports that the accuracy of niPGT does not meet the standards set by traditional biopsy methods.

Related Resources & Content

  1. American Society for Reproductive Medicine, ASRM, 2024 -- The use of preimplantation genetic testing for aneuploidy: a committee opinion
  2. BMC Medical Genomics, 2025 -- Noninvasive preimplantation genetic testing for aneuploidy using blastocyst spent culture medium may serve as a backup of trophectoderm biopsy in conventional preimplantation genetic testing
  3. Current status of spent embryo media research for preimplantation genetic testing - PMC
  4. Frontiers in Endocrinology — Genetic analysis of biopsy-related droplets in patients undergoing PGT-A and its potential application
  5. The Journal of Clinical Endocrinology & Metabolism — Outcomes of Perinatal and Maternal Health Following Transfer of Blastocysts from Nonpronuclear and Monopronuclear Embryos
  6. Frontiers in Endocrinology — Factors associated with de novo aneuploidy across different preimplantation genetic testing cycles: a retrospective cohort study
  7. Archives of Toxicology — Optimization and Standardization of the hiPSC-Derived PluriLum Assay for Identifying Embryonic and Developmental Toxicants
  8. The use of preimplantation genetic testing for aneuploidy: a committee opinion (2024) | American Society for Reproductive Medicine | ASRM
  9. Noninvasive preimplantation genetic testing for aneuploidy using blastocyst spent culture medium may serve as a backup of trophectoderm biopsy in conventional preimplantation genetic testing | BMC Medical Genomics | Full Text
  10. Current status of spent embryo media research for preimplantation genetic testing - PMC

Original Source(s)

Related Content